Home Compare MRNA vs WY
Stock Comparison · Structural lead, mixed market

Moderna vs Weyerhaeuser Company: Which Stock Looks Stronger in 2026?

Weyerhaeuser Company holds the cleaner structural position, with stability as the main driver and growth adding further support. In the market, Moderna carries the stronger setup — intact trend against Weyerhaeuser Company's broken trend. That leaves a split case: the structural lead stays with Weyerhaeuser Company, but the market is not currently confirming it.

The comparison is based on similar long-term financial trajectories, not sector labels.

Updated 2026-04-05

This is not just a one-metric split: both stability and growth materially support the lead. Weyerhaeuser Company leads by 12 points on the overall comparison score.

Trajectory Similarity
0.63
Moderately similar
Peer-set rank: #7
within Moderna, Inc.'s functional peer set

This pair is matched through long-term financial trajectory similarity within the selected peer universe.

The pair shares a valid long-term profile match, but the trajectories are not especially close.

Broad structural alignment across multiple dimensions, while margin consistency diverges substantially.

What reduces the match
margin consistency
How to read the score
0.85–1.00 · Very similar0.70–0.84 · Similar0.55–0.69 · Moderately similarbelow 0.55 · Loose match
Peer-Relative Score
MRNA
Moderna, Inc.
16
Peer-Score
Signal qualityHigh
vs
WY
Weyerhaeuser Company
28
Peer-Score
Signal qualityHigh

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

The largest gaps do not all point in the same direction.

Dimension spread: MRNA vs WY Profitability 15 18 Stability 3 35 Valuation 30 37 Growth 9 21 MRNA WY
Gap Ranking
#1 Stability +32
#2 Growth +12
#3 Valuation +7
#4 Profitability +3
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for MRNA and WY Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer MRNAWY Relative valuation Structural strength

The price setup looks more supportive for Weyerhaeuser Company, but Moderna, Inc. still has the stronger structure.

Valuation position uses peer-relative valuation score and peer-relative PE percentile (idx_pct_pe) where available.

Relative Position vs Comparable Companies
Stability
Both sit in the weaker half on stability, with Weyerhaeuser Company still coming out ahead.
Growth
Neither side looks especially strong on growth, though Moderna, Inc. still ranks somewhat higher.
Stability — Dominant Gap
MRNA
3
WY
35
Gap+32in favour of WY

The clearest distance comes from a steadier profile over time.

What keeps the gap from being one-sided

On the market side, Moderna carries the stronger trend while Weyerhaeuser Company's trend has broken — the market setup does not confirm the structural advantage.

What this means for the comparison

Stability is the clearest driver, and growth also supports Weyerhaeuser Company's broader structural position.

Explore full peer positioning in AssetNext

Break down the MRNA vs WY comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Similar stability-driven comparisons

Explore how MRNA and WY each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.